Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ai-Ris
AddedFeb 18, 2024
UpdatedJun 18, 2026
Ai-Ris

Ai-Ris

Angel

AI-Ris provides automated retinal exams via a portable headset, using machine learning for primary care.

HQ
College Station, TX, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Ai-Ris, founded with the mission to revolutionize disease detection, offers automated retinal examinations for primary care. Their core product is a portable headset that employs machine learning algorithms to screen for diseases such as diabetic retinopathy, AMD, and Alzheimer's Disease. This innovative system allows general practitioners to conduct retinal exams without the need for pupil dilation or specialist intervention, making early and precise detection more accessible.

Notable affiliated individuals and investors include experts in machine learning and healthcare technology, though specific names are not disclosed. Ai-Ris has achieved significant milestones, including securing U.S. patents for their technology and forming trusted partnerships within the medical community. Their impact is profound, addressing the leading cause of preventable blindness in adults and potentially transforming early disease detection on a global scale.

Ai-Ris - Similar Companies

Intelligent Retinal Imaging Systems logo

Intelligent Retinal Imaging Systems

Retina-Ai Health logo

Retina-Ai Health

Altris.AI logo

Altris.AI

altris.ai

Optain logo

Optain

optainhealth.com

Retina Technologies logo

Retina Technologies

Aeye Health logo

Aeye Health

aeyehealth.com

Insight Optics logo

Insight Optics

io.care

Vitazi.ai logo

Vitazi.ai

vitazi.ai

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Ocular Diagnostics logo

Ocular Diagnostics

Ainnova Tech logo

Ainnova Tech

ainnovatech.com

Airilabs logo

Airilabs

Avalon AI logo

Avalon AI

avalonai.com

IrisVision logo

IrisVision

irisvision.com

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Ai-Ris - Quick Facts

Who are Ai-Ris' competitors?

Companies similar to Ai-Ris include Intelligent Retinal Imaging Systems, Retina-Ai Health, Altris.AI and Optain.

When was Ai-Ris founded?

Ai-Ris was founded in 2020.

Where is Ai-Ris' headquarters located?

Ai-Ris' headquarters is located in College Station, TX, US.

When was Ai-Ris' last funding round?

Ai-Ris' most recent funding round was for $255.9k (USD) in March 2022.

How much has Ai-Ris raised to-date?

As of Mar 9, 2022, Ai-Ris has raised a total of $255.9k (USD).

How many employees does Ai-Ris have?

Ai-Ris has 5 employees as of Feb 4, 2024.

Ai-Ris - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified